Halpern Financial, Inc. Amgen Inc Transaction History

Halpern Financial, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Sep 21, 2023	SELL	$219.27 - $242.57 $110,950 - $122,740	-506 Closed	0 $0
Q4 2021 Sep 21, 2023	BUY	$198.88 - $227.6 $89,496 - $102,420	450 Added 803.57%	506 $114 Million
Q4 2020 Sep 21, 2023	SELL	$216.38 - $257.67 $9,737 - $11,595	-45 Reduced 44.55%	56 $12.9 Million
Q2 2020 Sep 21, 2023	BUY	$197.81 - $242.74 $8,901 - $10,923	45 Added 80.36%	101 $23.8 Million
Q4 2019 Sep 21, 2023	BUY	$189.21 - $243.2 $10,595 - $13,619	56 New	56 $13.5 Million

2,970

401M

6.59M

6.61M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $180B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Halpern Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Halpern Financial, Inc. with notifications on news.